Critical Safety Notice
Do not stop your disease-modifying therapy (DMT).
Stopping certain MS medicines—particularly natalizumab and fingolimod—can trigger a rebound (including severe relapses and extensive new MRI lesions). Published studies have reported serious rebound after natalizumab withdrawal, and similar rebound is well documented after fingolimod cessation.
After stopping medicines, disease activity commonly returns within about three months, whether or not bridging treatment is used.
Your DMT remains an important foundation of MS care, while Ayurveda can play a complementary role in supporting the symptoms and overall wellbeing of people living with MS.
Hanuveda’s Ayurvedic care focuses on the symptom burden of MS—including spasticity, pain, fatigue, bladder dysfunction—alongside your neurologist’s disease-modifying treatment.
The published Ayurvedic literature consists predominantly of individual case reports; rather that randomised controlled trials of Ayurvedic treatment for multiple sclerosis.
Management of Multiple Sclerosis Through Ayurveda: A Case Report- Journal of Ayurveda Case Reports. 2022;5(1). https://jaims.in/jaims/article/view/4
Effect of Ayurvedic and Panchakarma Treatment in Asthi Majja Gata Vata (Primary Progressive Multiple Sclerosis): A Case Study https://jahm.co.in/index.php/jahm/article/view/370
Ayurvedic Management of Multiple Sclerosis: A Case Report https://jaims.in/jaims/article/view/4711
In Ayurveda, MS is understood as an Anukta Vyādhi and interpreted mainly through the Vāta Vyādhi framework based on the individual’s symptoms and disease pattern.
Ayurvedic frameworks used in MS
MS needs a customized Ayurvedic plan. Standard Panchakarma may not suit every patient and can sometimes worsen symptoms, so therapies must be carefully adapted to the individual
Stage 0 — Assessment and neurological coordination
Before any therapy begins:
Three Key Changes in the MS Protocol
Stage 1 — Deepana, Pachana and bowel and bladder management
Agni correction, plus targeted management of the two systems MS damages most predictably.
Stage 2 — Snehana (oleation)
Stage 3 — Modified Swedana
As described above: dry bolus fomentation preferred, temperature and duration restricted, cooling protocols in place, heat-sensitive patients treated without sudation where necessary.
Stage 4 — Shodhana, When Appropriate
Stage 5 — Shiro-chikitsa
Stage 6 — Shamana & Rasayana
The focus is symptom support, strength and overall wellbeing—not immune stimulation. Medicines are selected individually and coordinated with ongoing MS treatment.
All medicines are individualized and reviewed for safety alongside the patient’s MS medications.
Stage 7 — The integrative component
Ayurvedic treatment in MS is symptomatic and supportive. It is not disease-modifying. Those outcomes belong to disease-modifying therapies, which have been tested in large randomised trials. What we work on is the daily symptom burden — which is what most patients with MS actually experience as their illness.
Outcomes we consider reasonable to expect
Outcomes we do not claim
Realistic timeline
How we measure it
No. MS is a chronic autoimmune condition of the central nervous system and no system of medicine can currently cure it. Ayurvedic management here is supportive and symptomatic — spasticity, pain, fatigue, bladder and bowel function, sleep and mood. Anyone promising you a cure for MS is not being truthful with you.
? No, and please do not. Stopping natalizumab or fingolimod in particular can cause rebound disease activity — severe relapses with extensive new MRI lesions that can exceed your pre-treatment disease activity. DMTs are what reduce your relapse rate and protect against disability accumulation. Ayurvedic treatment here runs alongside them.
Because of heat sensitivity, known as Uhthoff's phenomenon. Raising core body temperature slows nerve conduction in demyelinated axons and causes temporary worsening of MS symptoms — blurred vision, weakness, worse fatigue, imbalance. It is reversible and does not cause new damage, but it is distressing and increases fall risk. We substitute dry bolus fomentation and cooling therapies such as Takradhara, and we keep treatment rooms cool.
We would not assume that. Worsening during MS treatment has several possible causes, and most of them are not the treatment: a urinary or other infection causing a pseudo-relapse, overheating, overexertion, or a genuine new relapse. We investigate rather than explain it away. Attributing new neurological symptoms in MS to "toxins being released" is how real relapses get missed.
Diet is one of the more useful things we work on. The goals are an anti-inflammatory eating pattern, adequate fibre and fluid for bowel and bladder function, adequate vitamin D, and weight management — integrated with classical guidance on warm, easily digestible food. We are careful not to over-promise here: no diet has been shown to modify MS disease course, but several dietary factors affect symptom burden and general health substantially.
No. Acute relapses are managed by your neurologist, usually with corticosteroids. We wait until the relapse has been treated and you have stabilised. Coming to us instead of your neurologist during a relapse delays treatment that is time-sensitive.
It depends on your strength, and we will tell you honestly if we think it is not appropriate. Panchakarma is physically demanding and purgation is depleting. For some patients the right answer is Shamana therapy — internal medication, diet, oil massage, home programme — with no Shodhana at all. We would rather deliver less and have you tolerate it than complete a protocol at your expense.
No — the opposite of what you want. MS involves an immune system attacking your own myelin. Herbs marketed as immune boosters, particularly Guduchi/Giloy, are best avoided. A published case series documented six patients developing autoimmune-like hepatitis after Tinospora consumption, which the authors connected to its immune-stimulant action. We use anti-inflammatory and nervine herbs instead, and we do not prescribe immune tonics in autoimmune disease.
Patients seeking Ayurvedic treatment in India can avail of services tailored to their medical history, diagnosis, and prior treatments.
Our Doors Are Open for Your Healing Journey